
Pulmonx Corporation LUNG
€ 1.25
-5.56%
Quartalsbericht 2025-Q3
hinzugefügt 12.11.2025
Pulmonx Corporation Kurzfristige Verbindlichkeiten 2011-2026 | LUNG
Kurzfristige Verbindlichkeiten Jährlich Pulmonx Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24.4 M | 23.2 M | 18.5 M | 17.6 M | 12.5 M | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 24.4 M | 12.5 M | 19.2 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Aziyo Biologics
AZYO
|
43 M | - | 1.37 % | $ 20.5 M | ||
|
Bruker Corporation
BRKR
|
1.28 B | $ 38.92 | -0.89 % | $ 5.8 K | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | ||
|
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | ||
|
Cognyte Software Ltd.
CGNT
|
219 M | $ 8.16 | 4.35 % | $ 586 M | ||
|
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
87.7 M | - | -10.19 % | $ 1.99 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | ||
|
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | ||
|
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
25.3 M | - | - | $ 10.2 M | ||
|
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | ||
|
Second Sight Medical Products
EYES
|
5.99 M | - | -0.97 % | $ 54.4 M | ||
|
EDAP TMS S.A.
EDAP
|
37.8 M | $ 4.15 | 4.01 % | $ 155 M | ||
|
AdaptHealth Corp.
AHCO
|
712 M | $ 9.67 | 2.87 % | $ 1.31 B | ||
|
FONAR Corporation
FONR
|
16.7 M | $ 18.52 | 0.11 % | $ 121 M | ||
|
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | ||
|
Electromed
ELMD
|
10.5 M | $ 24.25 | 1.13 % | $ 205 M | ||
|
CONMED Corporation
CNMD
|
315 M | $ 43.28 | -0.3 % | $ 1.34 B | ||
|
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | ||
|
AxoGen
AXGN
|
23.6 M | $ 29.18 | -2.18 % | $ 1.34 B | ||
|
Apyx Medical Corporation
APYX
|
12.7 M | $ 3.32 | 4.57 % | $ 115 M | ||
|
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | ||
|
InMode Ltd.
INMD
|
70.7 M | $ 13.56 | -0.3 % | $ 876 M | ||
|
IRadimed Corporation
IRMD
|
8.51 M | $ 104.76 | 0.45 % | $ 1.33 B | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B | ||
|
Accuray Incorporated
ARAY
|
193 M | $ 0.53 | -0.13 % | $ 54.5 M | ||
|
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | ||
|
Cytosorbents Corporation
CTSO
|
9.82 M | $ 0.78 | -2.29 % | $ 42.5 M | ||
|
Medtronic PLC
MDT
|
12.9 B | $ 96.01 | -0.74 % | $ 123 B | ||
|
Align Technology
ALGN
|
2.04 B | $ 182.16 | -0.26 % | $ 13.6 B | ||
|
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | ||
|
Inari Medical
NARI
|
56.2 M | - | - | $ 4.23 B | ||
|
Butterfly Network
BFLY
|
48.2 M | $ 4.0 | 7.97 % | $ 847 M | ||
|
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | ||
|
Abbott Laboratories
ABT
|
16.5 B | $ 113.58 | - | $ 198 B | ||
|
NuVasive
NUVA
|
716 M | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
103 M | - | - | $ 217 M | ||
|
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
5.44 B | $ 72.71 | -1.54 % | $ 108 B | ||
|
Orthofix Medical
OFIX
|
170 M | $ 12.94 | -0.69 % | $ 512 M | ||
|
IRIDEX Corporation
IRIX
|
13 M | $ 1.42 | -0.7 % | $ 22.9 M |